Services Agreement for the production of fill finished vaccines for COVID-19 and therapeutics for use in the UK health system

The reservation of fill & finish manufacturing capacity at C P Pharmaceutical's Wrexham site for 18 months, which will provide capacity for vaccine in bulk product form to be converted into individual doses capable of roll out via a mass vaccination programme.

Additional information: This Contract Award Notice supersedes the already published notice that exists for this requirement, which can be found in the "links" section of this notice. This Award Notice has been published in order to include a redacted copy of the contract. This does not constitute an additional or separate agreement, and is merely a republication of the original notice.